Description
ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Location: PAMF (Peninsula/South Bay)
Please contact: Elizabeth Jameiro jameire@sutterhealth.org about study SERES 201
Principal Investigator
Co-Investigator(s)
Related Studies
Transforming Primary and Specialty Care for Inflammatory Bowel Disease
Use healthcare data to personalize the healthcare experience for people with inflammatory bowel disease.